Hansen Carl L. G.
SEC CIK 1834412 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABCL | AbCellera Biologics Inc. | CEO, Dir, 10% | 898.0K | — | — | 13 | 2021-11-18 | 2024-11-25 |
Most active insiders at ABCL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hayden Michael R | Dir | $1.05M | — |
| 2 | Thermopylae Holdings Ltd. | 10% | $711.0K | — |
| 3 | Booth Andrew | CFO | $529.6K | — |
| 4 | Montalbano John S. | Dir | $384.2K | — |
Hansen Carl L. G. made no open-market trades at ABCL in the last 12 months.
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-26 | 2024-11-25 | ABCL | AbCellera Biologics Inc. | Hansen Carl L. G. | CEO, Dir, 10% | M - OptEx | $2.70 | +56.1K | 898.0K | +7% | +$151.5K |
| D | 2024-09-24 | 2024-09-20 | ABCL | AbCellera Biologics Inc. | Hansen Carl L. G. | CEO, Dir, 10% | M - OptEx | $2.70 | +56.1K | 841.9K | +7% | +$151.5K |
| D | 2024-06-03 | 2024-05-31 | ABCL | AbCellera Biologics Inc. | Hansen Carl L. G. | CEO, Dir, 10% | M - OptEx | $2.70 | +56.1K | 785.8K | +8% | +$151.5K |
| D | 2024-02-27 | 2024-02-26 | ABCL | AbCellera Biologics Inc. | Hansen Carl L. G. | CEO, Dir, 10% | M - OptEx | $2.70 | +56.1K | 729.6K | +8% | +$151.5K |
| D | 2023-11-27 | 2023-11-23 | ABCL | AbCellera Biologics Inc. | Hansen Carl L. G. | CEO, Dir, 10% | M - OptEx | $2.70 | +56.1K | 673.5K | +9% | +$151.5K |
| D | 2023-08-25 | 2023-08-24 | ABCL | AbCellera Biologics Inc. | Hansen Carl L. G. | CEO, Dir, 10% | M - OptEx | $2.70 | +56.1K | 617.4K | +10% | +$151.5K |
| D | 2023-05-30 | 2023-05-26 | ABCL | AbCellera Biologics Inc. | Hansen Carl L. G. | CEO, Dir, 10% | M - OptEx | $2.70 | +56.1K | 561.2K | +11% | +$151.5K |
| D | 2023-02-23 | 2023-02-22 | ABCL | AbCellera Biologics Inc. | Hansen Carl L. G. | CEO, Dir, 10% | M - OptEx | $2.70 | +56.1K | 505.1K | +12% | +$151.5K |
| D | 2022-11-21 | 2022-11-18 | ABCL | AbCellera Biologics Inc. | Hansen Carl L. G. | CEO, Dir, 10% | M - OptEx | $2.70 | +56.1K | 449.0K | +14% | +$151.5K |
| D | 2022-08-22 | 2022-08-18 | ABCL | AbCellera Biologics Inc. | Hansen Carl L. G. | CEO, Dir, 10% | M - OptEx | $2.70 | +56.1K | 392.9K | +17% | +$151.5K |
| D | 2022-05-19 | 2022-05-18 | ABCL | AbCellera Biologics Inc. | Hansen Carl L. G. | CEO, Dir, 10% | M - OptEx | $2.70 | +56.1K | 336.8K | +20% | +$151.5K |
| D | 2022-02-25 | 2022-02-22 | ABCL | AbCellera Biologics Inc. | Hansen Carl L. G. | CEO, Dir, 10% | M - OptEx | $2.70 | +56.1K | 280.6K | +25% | +$151.5K |
| D | 2021-11-22 | 2021-11-18 | ABCL | AbCellera Biologics Inc. | Hansen Carl L. G. | CEO, Dir, 10% | M - OptEx | $15.03 | +224.5K | 224.5K | New | +$3.37M |
Purchase Sale Sale after option exercise All abbreviations